|Bid||270.97 x 800|
|Ask||271.19 x 800|
|Day's Range||268.06 - 273.19|
|52 Week Range||205.10 - 288.27|
|Beta (5Y Monthly)||0.78|
|PE Ratio (TTM)||70.42|
|Earnings Date||Oct 25, 2021 - Oct 29, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Nov 23, 2012|
|1y Target Est||298.80|
Masimo's (MASI) EMMA is likely to aid in maintaining an optimal range of PaCO2 in preterm infants undergoing mechanical ventilation in the neonatal intensive care unit.
TOKYO, September 26, 2021--A new study found that the Masimo EMMA® Portable Capnograph "may be considered an effective monitoring device" for mechanically ventilated neonates.
Investors continue to be optimistic about Masimo (MASI) owing to its slew of product launches and regulatory approvals.